Hikma Pharmaceuticals Plc Dividend Declaration (7825P)
October 04 2013 - 9:01AM
UK Regulatory
TIDMHIK
RNS Number : 7825P
Hikma Pharmaceuticals Plc
04 October 2013
Hikma Pharmaceuticals PLC
Interim & Special Dividend for 2013
LONDON, 4 October 2013 - Hikma Pharmaceuticals PLC ("the
Company") advises that, as previously announced with the interim
results, the Company is paying a total dividend of 10 cents per
share, comprising the interim dividend of 7.0 cents and the special
dividend of 3 cents, on 7 October 2013 to shareholders on the
register on 6 September 2013.
Shareholders who have elected to receive their dividend in
Pounds Sterling will receive 6.26 pence per Ordinary Share
(exchange rate US$1.5974 to GBPGBP1).
Shareholders who have elected to receive their dividend in
Jordanian Dinar will receive 7.08 qirsh (piastres) per Ordinary
Share (exchange rate US$0.708 to JOD1).
- ENDS -
Enquiries:
Hikma Pharmaceuticals PLC
Peter Speirs
Company Secretary +44 20 7399 2670
Susan Ringdal
Investor Relations Director +44 20 7399 2670
About Hikma
Hikma Pharmaceuticals PLC is a fast growing pharmaceutical group
focused on developing, manufacturing and marketing a broad range of
both branded and non-branded generic and in-licensed products.
Hikma's operations are conducted through three businesses:
"Branded", "Injectables" and "Generics" based primarily in the
Middle East and North Africa ("MENA") region, where it is a market
leader, the United States and Europe. In 2012, Hikma achieved
revenues of $1,108.7 million and profit attributable to
shareholders of $100.3 million.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DIVMIBJTMBMMBMJ
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024